Upcoming Visits

Upcoming FDA Visits:

Dates Topic FDA Visitors

March 21, 2017

Trends in Regulatory Science

Frank Weichold, MD, PhD | Director, Critical Path and Regulatory Science Initiatives, Office of the Chief Scientist

 

November 2017

Oncology Products

Geoffrey Kim, MD | Director, Division of Oncology Products 1/OHOP, CDER

 

TBD

Pharmacovigilence

Robert Ball, MD | Deputy Director, Office of Surveillance and Epidemiology, CDER
Scott Proestel, MD | Director, Division of Pharmacovigilance II/OSE, CDER

 

TBD

Biostatistics

Thomas Permutt, PhD | Director, Division of Biometrics II/OB, CDER

 

TBD

Cellular Immunotherapies

TBD

 

TBD

Orphan Drugs

TBD

 

TBD

CRISPR/Cas9 Genome Editing

TBD

 

Public lectures are posted under the "Events" link on the left menu bar.  Please contact Lawrence Lin to learn more about any of the upcoming visits.